Yasir B. Al-Wakeel Insider Profile
11 Followers
Yasir B. Al-Wakeel, Director at MaxCyte, holds 81.00K shares in MaxCyte (Ticker: MXCT), holds 0.00 shares in Merrimack Pharmaceuticals (Ticker: MACK), holds 346.10K shares in Kronos Bio (Ticker: KRON).
Yasir B. Al-Wakeel's Trading History
| MXCTMaxCyte | Jun 22, 2026 | Director | Uninformative Buy | ― | $95.58K | |
| KRONKronos Bio | Jul 07, 2023 | ― | Informative Sell | 16.83K | $304.57K | |
| NTGNNeon Therapeutics | May 06, 2020 | ― | Uninformative Sell | ― | $0.00 | |
| MACKMerrimack Pharmaceuticals | ― | ― | ― | $0.00 |
You May Also Like
Yasir B. Al-Wakeel insider profile FAQ
What is the percentage of profitable transactions made by Yasir B. Al-Wakeel?
The percentage of profitable transactions made by Yasir B. Al-Wakeel is 67%.
What is the average return per transaction made by Yasir B. Al-Wakeel?
The average return per transaction made by Yasir B. Al-Wakeel is 10.10%.
What stocks does Yasir B. Al-Wakeel hold?
Yasir B. Al-Wakeel holds: MXCT, MACK, NTGN, KRON stocks.
What was Yasir B. Al-Wakeel's most profitable transaction?
Yasir B. Al-Wakeel’s most profitable transaction was an Informative Sell of KRON stock on July 7, 2023. The return on the trade was 42.20%.
What is Yasir B. Al-Wakeel's role in MaxCyte?
Yasir B. Al-Wakeel's role in MaxCyte is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
